
    
      Purpose: the aim of this study is to evaluate the potential beneficial antitumoral effect of
      LMWH enoxaparin in patients with locally advanced or metastatic NSCLC determined by the time
      to progression, the overall survival and the symptom control. LMWH will be added to a first
      line cisplatin-based chemotherapy.
    
  